Showing results (941-950 of 990) with videos related to
Sort By:
Pageof 99
NPJ Precision Oncology|January 3, 2025
Assessment of targets of antibody drug conjugates in SCLCAbhishek Ajay, Han Wang, Ali Rezvani, et al.Mayo Clinic Proceedings|November 22, 2005
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical featuresFarid H Mahmud, Joseph A Murray, Yogish C Kudva, et al.Arthritis and Rheumatism|June 17, 2000
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study GroupA D Moore, M A Petri, S Manzi, et al.Rheumatology (Oxford, England)|March 11, 2005
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-beingP Panopalis, M Petri, S Manzi, et al.Medicine|September 3, 2014
Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatmentJames Riddell, Carol A Kauffman, Jeannina A Smith, et al.Journal of Clinical Microbiology|April 11, 2014
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesPaschalis Vergidis, Raymund R Razonable, L Joseph Wheat, et al.Blood|September 25, 2020
Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell diseaseL Joseph, C Jean, S Manceau, et al.The Journal of Rheumatology|July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, M A Petri, S Manzi, et al.Journal of the National Cancer Institute|November 16, 2006
Age-related lobular involution and risk of breast cancerTia R Milanese, Lynn C Hartmann, Thomas A Sellers, et al.Cancer|September 20, 2024
Identification of HEPACAM2 as a novel and specific marker of small cell carcinomaKaren S McColl, Abhishek Ajay, Han Wang, et al.Pageof 99